183 related articles for article (PubMed ID: 26230881)
1. Inosine 5'-monophosphate dehydrogenase inhibitors as antimicrobial agents: recent progress and future perspectives.
Shah CP; Kharkar PS
Future Med Chem; 2015; 7(11):1415-29. PubMed ID: 26230881
[TBL] [Abstract][Full Text] [Related]
2. The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors.
Hedstrom L; Liechti G; Goldberg JB; Gollapalli DR
Curr Med Chem; 2011; 18(13):1909-18. PubMed ID: 21517780
[TBL] [Abstract][Full Text] [Related]
3. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
Nair V; Shu Q
Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
[TBL] [Abstract][Full Text] [Related]
4. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.
Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A
J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472
[TBL] [Abstract][Full Text] [Related]
5. Inosine 5'-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases.
Ratcliffe AJ
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):595-605. PubMed ID: 17002220
[TBL] [Abstract][Full Text] [Related]
6. Inosine monophosphate dehydrogenase as a target for antiviral, anticancer, antimicrobial and immunosuppressive therapeutics.
Braun-Sand SB; Peetz M
Future Med Chem; 2010 Jan; 2(1):81-92. PubMed ID: 21426047
[TBL] [Abstract][Full Text] [Related]
7. Novel inhibitors of inosine monophosphate dehydrogenase in patent literature of the last decade.
Petrelli R; Vita P; Torquati I; Felczak K; Wilson DJ; Franchetti P; Cappellacci L
Recent Pat Anticancer Drug Discov; 2013 May; 8(2):103-25. PubMed ID: 23016672
[TBL] [Abstract][Full Text] [Related]
8. Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors: a patent and scientific literature review (2002-2016).
Cuny GD; Suebsuwong C; Ray SS
Expert Opin Ther Pat; 2017 Jun; 27(6):677-690. PubMed ID: 28074661
[TBL] [Abstract][Full Text] [Related]
9. Inosine 5'-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents.
Fotie J
Mini Rev Med Chem; 2018; 18(8):656-671. PubMed ID: 27334467
[TBL] [Abstract][Full Text] [Related]
10. [The determination and clinical application of inosine 5’-monophosphate dehydrogenase activity].
Liu FY; Qiu XY; Jiao Z
Yao Xue Xue Bao; 2016 Nov; 51(11):1666-73. PubMed ID: 29908108
[TBL] [Abstract][Full Text] [Related]
11. [The basic functions of inosine 5'-monophosphate dehydrogenase and its application in drug discovery].
Zhang YW; Zhang D; Sun H
Yao Xue Xue Bao; 2014 Mar; 49(3):285-92. PubMed ID: 24961097
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
Shah CP; Kharkar PS
Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of the inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Cholewiński G; Iwaszkiewicz-Grześ D; Prejs M; Głowacka A; Dzierzbicka K
J Enzyme Inhib Med Chem; 2015; 30(4):550-63. PubMed ID: 25198892
[TBL] [Abstract][Full Text] [Related]
14. A potent "fat base" nucleotide inhibitor of IMP dehydrogenase.
Wang W; Hedstrom L
Biochemistry; 1998 Aug; 37(34):11949-52. PubMed ID: 9718319
[TBL] [Abstract][Full Text] [Related]
15. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors.
Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS
Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922
[TBL] [Abstract][Full Text] [Related]
16. Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis.
Trapero A; Pacitto A; Singh V; Sabbah M; Coyne AG; Mizrahi V; Blundell TL; Ascher DB; Abell C
J Med Chem; 2018 Apr; 61(7):2806-2822. PubMed ID: 29547284
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of curcumin on IMP dehydrogenase, the target for anticancer and antiviral chemotherapy agents.
Dairaku I; Han Y; Yanaka N; Kato N
Biosci Biotechnol Biochem; 2010; 74(1):185-7. PubMed ID: 20057137
[TBL] [Abstract][Full Text] [Related]
19. A three-dimensional pharmacophore model for IMPDH inhibitors.
Yang N; Wang J; Li J; Wang QH; Wang Y; Cheng MS
Chem Biol Drug Des; 2011 Jul; 78(1):175-82. PubMed ID: 21507206
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Dunkern T; Chavan S; Bankar D; Patil A; Kulkarni P; Kharkar PS; Prabhu A; Goebel H; Rolser E; Burckhard-Boer W; Arumugam P; Makhija MT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):408-19. PubMed ID: 23663081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]